Your Location：
Home >
Browse articles >
Traditional Chinese Medicine Manages Lung Cancer Based on Epigenetic Regulation： A Review
Updated：2026-10-16
Previous|Next

    • Traditional Chinese Medicine Manages Lung Cancer Based on Epigenetic Regulation： A Review

      Enhanced Publication
    • “Traditional Chinese medicine and its active ingredients have shown unique advantages and potential in regulating epigenetics for the prevention and treatment of lung cancer. This article introduces the research progress in the field of epigenetics regulation, and experts have summarized the basic and clinical research of traditional Chinese medicine intervention in lung cancer, providing reference for exploring new strategies for the prevention and treatment of lung cancer.”
    • WANG Ying , ZOU Jiyu , LIU Yongming , WANG Shiwen , CAO Tianya , MA Xuenan , ZANG Ningzi
    • Chinese Journal of Experimental Traditional Medical Formulae Vol. 32, Issue 22, Pages: 265-276(2026)

    • DOI： 10.13422/j.cnki.syfjx.20260864     

      CLC：

    • Revised：2026-07-09 ，

      Accepted：09 July 2026 ，

    Scan QR Code

  •  
  •  

  • AI Introduction

  • Full Text(HTML)

  • Figs( 3 ) Tabs( 0 )

  • References

  • Publication Info

  • Metrics

50

Views

5

Downloads

0

CSCD

Alert me when the article has been cited
Submit
Tools
  • BibTeXDownload
  • EndnoteDownload
  • RefMan Download
  • NoteExpressDownload
  • NoteFirstDownload

Related Articles

Mechanism of Treatment of Hepatocellular Carcinoma with Traditional Chinese Medicine Based on Epigenetic Regulation： A Review
Histone Modification with Traditional Chinese Medicine in Prevention and Treatment of Atherosclerosis： A Review
Application of ''Sensation and Response'' Theory in Syndrome Differentiation and Treatment of Lung Cancer
Mechanism of Xixintang in Protecting Blood-brain Barrier in Alzheimer's Disease Model Rats Based on AQP4 Polarization
Regulatory Effect and Mechanisms of Liuhuang Zhike Prescription on Glycemic Control in db/db Mice via AMPK/Akt/GSK-3β Signaling Pathway

Related Author

ZHU Yongping
LIU Yanqing
GU Liwei
ZHANG Junzhe
XU Xianyu
SHEN Shengnan
WANG Jigang
XU Xianyu

Related Institution

Center for Drug Research and Development，Guangdong Provincial Key Laboratory of Advanced Drug Delivery System，Guangdong Pharmaceutical University
Institute of Chinese Materia Medica，China Academy of Chinese Medical Sciences， State Key Laboratory for Quality Ensurange and Sustainable Use of Dao-di Herbs
Artemisinin Research Center and Institute of Chinese Materia Medica， China Academy of Chinese Medical Sciences
Liaoning University of Traditional Chinese Medicine（TCM）
Affiliated Hospital of Liaoning University of TCM